A double blind placebo controlled, 4-way crossover study was carried out to investigate the pharmacokinetics of single oral doses of xipamide (lOmg), triamterene (30mg) and Trirexan <10mg xipamide + 30mg triamterene) in a group of 12 healthy male volunteers. HPLC assays were developed for the measurement of both drugs in plasma. Plasma levels of xipamide and triamterene were measured using these validated HPLC methods. The individual plasma level data are presented as tables and the mean plasma levels are presented graphically. Plasma xipamide levels measured over a 24 hour period after dosing with xipamide alone and in a fixed combination as Trirexan were analysed using the JANA curve stripping program. The estimates of the p...
In the anticancer drug discovery and therapy development, it is essential to understand the pharmaco...
A novel, simple and robust high-performance liquid chromatography (HPLC) method was developed and va...
Two highly homologous enzymes, cytochrome P450 enzyme 3A4 (CYP3A4) and CYP3A5 play predominant roles...
A double blind placebo controlled, 4-way crossover study was carried out to investigate the pharma...
A double blind placebo controlled, 4-way crossover study was carried out to investigate the pharma...
Validated, rapid and sensitive spectrophotometric techniques were established for simultaneous deter...
A novel, simple and robust high-performance liquid chromatography (HPLC) method was developed and va...
A novel, simple and robust high-performance liquid chromatography (HPLC) method was developed and va...
When drug interference is suspected, a pharmacokinetic study is safer for patients than a large-sca...
When drug interference is suspected, a pharmacokinetic study is safer for patients than a large-sca...
In the anticancer drug discovery and therapy development, it is essential to understand the pharmaco...
When drug interference is suspected, a pharmacokinetic study is safer for patients than a large-sca...
In the anticancer drug discovery and therapy development, it is essential to understand the pharmaco...
In the field of pharmacokinetics, cytochrome P450 enzymes have been extensively studied. The CYP450 ...
In the anticancer drug discovery and therapy development, it is essential to understand the pharmaco...
In the anticancer drug discovery and therapy development, it is essential to understand the pharmaco...
A novel, simple and robust high-performance liquid chromatography (HPLC) method was developed and va...
Two highly homologous enzymes, cytochrome P450 enzyme 3A4 (CYP3A4) and CYP3A5 play predominant roles...
A double blind placebo controlled, 4-way crossover study was carried out to investigate the pharma...
A double blind placebo controlled, 4-way crossover study was carried out to investigate the pharma...
Validated, rapid and sensitive spectrophotometric techniques were established for simultaneous deter...
A novel, simple and robust high-performance liquid chromatography (HPLC) method was developed and va...
A novel, simple and robust high-performance liquid chromatography (HPLC) method was developed and va...
When drug interference is suspected, a pharmacokinetic study is safer for patients than a large-sca...
When drug interference is suspected, a pharmacokinetic study is safer for patients than a large-sca...
In the anticancer drug discovery and therapy development, it is essential to understand the pharmaco...
When drug interference is suspected, a pharmacokinetic study is safer for patients than a large-sca...
In the anticancer drug discovery and therapy development, it is essential to understand the pharmaco...
In the field of pharmacokinetics, cytochrome P450 enzymes have been extensively studied. The CYP450 ...
In the anticancer drug discovery and therapy development, it is essential to understand the pharmaco...
In the anticancer drug discovery and therapy development, it is essential to understand the pharmaco...
A novel, simple and robust high-performance liquid chromatography (HPLC) method was developed and va...
Two highly homologous enzymes, cytochrome P450 enzyme 3A4 (CYP3A4) and CYP3A5 play predominant roles...